KRAS and colorectal cancer: In colorectal cancer, TRIM21-mediated K63 ubiquitination reduces the stability of the hnRNPA2B1 protein, leading to a decline in nuclear export and translation of KRAS mRNA, and reduced activation of the MAPK signaling pathway, ultimately inhibiting the malignant progression of colorectal cancer [43].